Ky. High Court Nixes Fen-Phen Malpractice Suit Against Firms

Law360, New York (October 24, 2013, 9:06 PM ET) -- The Kentucky Supreme Court on Thursday affirmed the dismissal of a malpractice suit accusing two law firms and another attorney of shorting 50 users of the diet drug fen-phen on their shares of a $215 million product liability settlement with the drug's manufacturer, ruling the claims were time-barred.

In a 5-2 ruling, the state high court found that 50 alleged fen-phen victims discovered “with mathematical certainty” by October 2006 that they had been underpaid on settlement checks their former lawyers disbursed in 2001. They nonetheless waited...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required